INSP
Undervalued by 167.3% based on the discounted cash flow analysis.
Market cap | $2.77 Billion |
---|---|
Enterprise Value | $2.70 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $1.8 |
Beta | 1.22 |
Outstanding Shares | 29,507,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 52.04 |
---|---|
PEG | -38.08 |
Price to Sales | 2.98 |
Price to Book Ratio | 3.93 |
Enterprise Value to Revenue | 3.13 |
Enterprise Value to EBIT | 42.86 |
Enterprise Value to Net Income | 50 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.05 |
No data
No data
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and onl...